Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.
Alpha-1 Proteinase Inhibitor Market contains market size and forecasts of Alpha-1 Proteinase Inhibitor in global, including the following market information:
- Global Alpha-1 Proteinase Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Alpha-1 Proteinase Inhibitor Market Sales, 2017-2022, 2023-2028, (K Units)
- Global top five Alpha-1 Proteinase Inhibitor companies in 2021 (%)
The global Alpha-1 Proteinase Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Alpha-1 Proteinase Inhibitor include Takeda, Kamada, Grifols and CSL Behring, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- surveyed the Alpha-1 Proteinase Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alpha-1 Proteinase Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Alpha-1 Proteinase Inhibitor Market Segment Percentages, by Type, 2021 (%)
Global Alpha-1 Proteinase Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Alpha-1 Proteinase Inhibitor Market Segment Percentages, by Application, 2021 (%)
Global Alpha-1 Proteinase Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Alpha-1 Proteinase Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Alpha-1 Proteinase Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Alpha-1 Proteinase Inhibitor revenues share in global market, 2021 (%)
- Key companies Alpha-1 Proteinase Inhibitor sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Alpha-1 Proteinase Inhibitor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Takeda
- Kamada
- Grifols
- CSL Behring
